Abstract Background: Artistic creativity is often observed in individuals with schizoaffective disorder, bipolar type, while medication adherence can be compromised…
Abstract Background: The initial stages of bipolar disorder (BD) and schizophrenia (SCZ) often exhibit depressive symptoms and syndromes, leading to…
Abstract Background: The Canadian Network for Mood and Anxiety Treatments (CANMAT) publishes clinical practice guidelines for mood and anxiety disorders.…
Abstract Background: Data are needed on differences in community-dwelling populations with bipolar disorder (BP) regarding trust in research and access…
Abstract Background: Problematic cannabis use is highly prevalent among people with mood disorders. This underscores the need to understand the…
Abstract Introduction: Structural brain connectivity abnormalities have been associated with several psychiatric disorders. Schizophrenia (SCZ) is a chronic disabling disorder…
Abstract Background: Cannabis use is a risk factor of psychiatric illness, such as bipolar disorder type-I (BDI). Indeed, cannabis use…
Abstract Cannabis use has been stated as a causal risk factor for the occurrence of schizophrenia and other psychotic disorders.…
Abstract Introduction: The endocannabinoid (eCB) system disruption has been suggested to underpin the development of psychosis, fueling the search for…
Abstract Background: Cannabis use is a global public health issue associated with increased risks of developing mental health disorders, especially…